Pyxis Diagnostics
AI-powered Cancer Diagnostics Platform for Predicting Immuno-oncology Drug Response
Active
Seed
Startup
Jerusalem
Founded 2019-04
Pyxis Diagnostics is developing an AI-powered cancer diagnostics platform for predicting immuno-oncology (IO) drug response. The company's platform can predict IO drug response for many cancer types. It can also suggest alternative treatment routes in cases when the predicted drug response is low, improving the quality of life of oncological patients. Biolo…
SectorHealth Tech & Life Sciences
StageSeed
Total raised$1.2M
Employees4
Founded2019-04
HQJerusalem
Confidence97
Sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technology
Artificial IntelligenceMachine LearningBiologicals
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesPharmaceuticals